Lot of pharma companies have started paying attention to OTC brands. This adds another revenue stream to their portfolio of products which is out price control regime and not affected by US FDA/UK MHRA inspection scares. This also helps them to migrate from pure “pharma” to quasi FMCG-pharma company. Piramal has been making conscious effort by acquiring brands like Saridon, Lacto Calamine, I-pill etc. Recent acquisition seems to in line with their OTC strategy.
Please see the article in Outlook Business about OTC brands
http://www.outlookbusiness.com/strategy/feature/if-youve-got-it-flaunt-it-1970
Disc : invested
| Subscribe To Our Free Newsletter |
